Nuwellis, Inc. - 8-K Filing

Nuwellis reports Q3 2026 results with $2.2M net sales and a 24% improvement in operating loss driven by gross margin expansion. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)

SEC EDGAR · November 12, 2026, 21:03 UTC

Tickers: $NUWE

Read the full article at SEC EDGAR

Part of the story Lifeway Foods, Inc. - 8-K Filing (3 articles)

More Regulatory news

Nakamoto Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 21:35 UTC
enCore Energy Corp. - 10-Q Filing SEC EDGAR · November 12, 2026, 21:34 UTC
Cibus, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 21:34 UTC
Spero Therapeutics, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 21:34 UTC
PepGen Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 21:34 UTC
WhiteHawk Minerals Corp. - 8-K Filing SEC EDGAR · November 12, 2026, 21:34 UTC
Altimmune, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 21:33 UTC
LifeStance Health Group, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 21:32 UTC
Net Power Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 21:31 UTC
FIRST KEYSTONE CORP - 10-Q Filing SEC EDGAR · November 12, 2026, 21:31 UTC